HR 8816 · 118th Congress · Health
American Medical Innovation and Investment Act of 2024
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-958, Part I.(2024-12-27)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 8816 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 8816 To amend title XVIII of the Social Security Act to provide for a cognitive impairment detection benefit under the Medicare program, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES June 25, 2024 Mr. Buchanan introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend title XVIII of the Social Security Act to provide for a cognitive impairment detection benefit under the Medicare program, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``American Medical Innovation and …
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeH.R. 8816, American Medical Innovation and Investment Act of 2024
Dec 20, 2024As ordered reported by the House Committee on Ways and Means on May 8, 2024, and June 27, 2024
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office